In recent years, the production of recombinant pharmaceutical proteins in heterologous systems has increased significantly.\nMost applications involve complex proteins and glycoproteins that are difficult to produce, thus promoting the development and\nimprovement of a wide range of production platforms. No individual system is optimal for the production of all recombinant\nproteins, so the diversity of platforms based on plants offers a significant advantage. Here, we discuss the production of four\nrecombinant pharmaceutical proteins using different platforms, highlighting from these examples the unique advantages of plantbased\nsystems over traditional fermenter-based expression platforms.
Loading....